Measuring and Valuing Outcomes
We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.
OHE and Peking University of China to Collaborate on Research to Explore the Inconsistent Ordering of Levels of the EQ-5D-5L Value Set
21 July 2015
This post summarises a research grant that OHE and Peking University have been awarded from the EuroQol Group Foundation. The funded research project will explore the…
An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies
7 July 2015
A paper by OHE’s Koonal Shah on alternative comparators for use in TTO studies is the first to be published as part of the new EuroQol…
Patient-reported outcomes measures (PROMs) in Health Economics – an Overview and Key Developments in the Field
30 June 2015
In June 2015 OHE’s Nancy Devlin gave a seminar at the Royal Statistical Society on the topic of patient-reported outcomes measures (PROMs) in health economics –…
PriMHE Lecture: Relative Effectiveness and the Impact on Drug Development
28 May 2015
OHE’s Adrian Towse will give a lecture at the Medical University of Vienna on relative effectiveness and the impact on drug development.
OHE’s Professor Nancy Devlin and Koonal Shah Join the EuroQol Research Foundation’s Valuation Working Group
5 May 2015
OHE’s Professor Nancy Devlin and Koonal Shah have both been appointed to serve on the Valuation Working Group of the EuroQol Research Foundation.
international Decision Support Initiative (iDSI): Mapping of Priority-setting in Health in 17 Low and Middle Income Countries Across Asia, Latin America and Africa
22 April 2015
This mapping of priority-setting considers factors such as existence of HTA institutions and commitment to UHC (Brazil, Chile, Colombia, Mexico, Uruguay, Ghana, Kenya, Malawi, South Africa,…
OHE Publishes in the Journal of Comparative Effectiveness Research: Future Expectations of Evidence of Relative Effectiveness in Europe and Comparative Effectiveness in the USA in 2020
15 April 2015
Articles co-authored by Adrian Towse, Martina Garau, Donna Messner, and Penny Mohr exploring future expectations of drug relative effectiveness in Europe and comparative effectiveness in the…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
A new OHE Consulting Report considers the data capabilities in the UK for monitoring medicine use according to indication using real world data.
A Framework for Payer Assessment of the Value of New Technologies: A US Approach
10 March 2015
Dr Steven Pearson has convened a US policy workgroup of payers, drug and device manufacturers, patients’ groups, and clinician specialty societies to help develop a “value…